Cell-Free DNA (cfDNA) Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type ( donor derived cell free DNA (ddcfDNA), circulating cell-free tumor DNA (ctDNA), cell-free fetal DNA (NIPT) ); Application ( oncology, gynecology, transplantation )
Report Code: TIPRE00011771 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
Cell-Free DNA are fragments of DNA that circulate in the blood fluid and can be utilized as valuable biomarkers. It is a new technology in which a small quantity of liquid sample (saliva, urine, or blood) from the patient is collected to examine the freely flowing DNA. Cell-Free DNA (cfDNA) is a noninvasive screening test used to help detect graft rejection, identify mutations in cancer patients, and detect various chromosomal abnormalities in the fetus to know the gender of the fetus. The discovery of cfDNA has opened up to new potentials in the field of oncology, gynecology, transplantation, and infectious diseases.
MARKET DYNAMICS
The cell-free DNA (cfDNA) testing market is driving due to the Increased incidences of diseases like chromosomal abnormalities due to increase in maternal age, changing lifestyle, unhealthy diet habits and rising prevalence of cancer. However, lack of standardization, unfavorable reimbursement policies and legal and regulatory guidelines some of the reasons hampering the growth of the market. Moreover, increasing healthcare expenditure and rising healthcare awareness are driving the cell-free DNA market.
MARKET SCOPE
The "Cell-Free DNA (cfDNA) Testing Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of cell-free DNA (cfDNA) testing market with detailed market segmentation by type and application. The cell-free DNA (cfDNA) testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in cell-free DNA (cfDNA) testing market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The cell-free DNA (cfDNA) testing market is segmented on the basis of type and application. Based on type, the market is segmented as donor derived cell free DNA (ddcfDNA), circulating cell-free tumor DNA (ctDNA) and cell-free fetal DNA (NIPT). On the basis of application, the market is categorized as oncology, gynecology and transplantation.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the cell-free DNA (cfDNA) testing market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cell-free DNA (cfDNA) testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting cell-free DNA (cfDNA) testing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cell-free DNA (cfDNA) testing market in these regions.
The report covers key developments in the cell-free DNA (cfDNA) testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from cell-free DNA (cfDNA) testing market are anticipated to have lucrative growth opportunities in the future with the rising demand for cell-free DNA (cfDNA) testing in the global market. Below mentioned is the list of few companies engaged in the cell-free DNA (cfDNA) testing market.
The report also includes the profiles of key players in cell-free DNA (cfDNA) testing market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Cell-Free DNA are fragments of DNA that circulate in the blood fluid and can be utilized as valuable biomarkers. It is a new technology in which a small quantity of liquid sample (saliva, urine, or blood) from the patient is collected to examine the freely flowing DNA. Cell-Free DNA (cfDNA) is a noninvasive screening test used to help detect graft rejection, identify mutations in cancer patients, and detect various chromosomal abnormalities in the fetus to know the gender of the fetus. The discovery of cfDNA has opened up to new potentials in the field of oncology, gynecology, transplantation, and infectious diseases.
MARKET DYNAMICS
The cell-free DNA (cfDNA) testing market is driving due to the Increased incidences of diseases like chromosomal abnormalities due to increase in maternal age, changing lifestyle, unhealthy diet habits and rising prevalence of cancer. However, lack of standardization, unfavorable reimbursement policies and legal and regulatory guidelines some of the reasons hampering the growth of the market. Moreover, increasing healthcare expenditure and rising healthcare awareness are driving the cell-free DNA market.
MARKET SCOPE
The "Cell-Free DNA (cfDNA) Testing Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of cell-free DNA (cfDNA) testing market with detailed market segmentation by type and application. The cell-free DNA (cfDNA) testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in cell-free DNA (cfDNA) testing market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The cell-free DNA (cfDNA) testing market is segmented on the basis of type and application. Based on type, the market is segmented as donor derived cell free DNA (ddcfDNA), circulating cell-free tumor DNA (ctDNA) and cell-free fetal DNA (NIPT). On the basis of application, the market is categorized as oncology, gynecology and transplantation.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the cell-free DNA (cfDNA) testing market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cell-free DNA (cfDNA) testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting cell-free DNA (cfDNA) testing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cell-free DNA (cfDNA) testing market in these regions.
The report covers key developments in the cell-free DNA (cfDNA) testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from cell-free DNA (cfDNA) testing market are anticipated to have lucrative growth opportunities in the future with the rising demand for cell-free DNA (cfDNA) testing in the global market. Below mentioned is the list of few companies engaged in the cell-free DNA (cfDNA) testing market.
The report also includes the profiles of key players in cell-free DNA (cfDNA) testing market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Agilent Technology
- Allenex AB
- Biocept, Inc.
- Biodesix, Inc.
- CareDx, Inc.
- Guardant Health, Inc.
- Illumania, Inc.
- Inivated Limited, Natera, Inc.
- Quest Diagnostics
- Roche Holdings AG
- Sequenom, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cell-Free DNA (cfDNA) Testing Market - By Type
1.3.2 Cell-Free DNA (cfDNA) Testing Market - By Application
1.3.3 Cell-Free DNA (cfDNA) Testing Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CELL-FREE DNA (CFDNA) TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CELL-FREE DNA (CFDNA) TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CELL-FREE DNA (CFDNA) TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. CELL-FREE DNA (CFDNA) TESTING - GLOBAL MARKET OVERVIEW
6.2. CELL-FREE DNA (CFDNA) TESTING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. CELL-FREE DNA (CFDNA) TESTING MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. DONOR DERIVED CELL FREE DNA (DDCFDNA)
7.3.1. Overview
7.3.2. donor derived cell free DNA (ddcfDNA) Market Forecast and Analysis
7.4. CIRCULATING CELL-FREE TUMOR DNA (CTDNA)
7.4.1. Overview
7.4.2. circulating cell-free tumor DNA (ctDNA) Market Forecast and Analysis
7.5. CELL-FREE FETAL DNA (NIPT)
7.5.1. Overview
7.5.2. cell-free fetal DNA (NIPT) Market Forecast and Analysis
8. CELL-FREE DNA (CFDNA) TESTING MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ONCOLOGY
8.3.1. Overview
8.3.2. oncology Market Forecast and Analysis
8.4. GYNECOLOGY
8.4.1. Overview
8.4.2. gynecology Market Forecast and Analysis
8.5. TRANSPLANTATION
8.5.1. Overview
8.5.2. transplantation Market Forecast and Analysis
9. CELL-FREE DNA (CFDNA) TESTING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Cell-Free DNA (cfDNA) Testing Market Overview
9.1.2 North America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis
9.1.3 North America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Type
9.1.4 North America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Application
9.1.5 North America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Countries
9.1.5.1 United States Cell-Free DNA (cfDNA) Testing Market
9.1.5.1.1 United States Cell-Free DNA (cfDNA) Testing Market by Type
9.1.5.1.2 United States Cell-Free DNA (cfDNA) Testing Market by Application
9.1.5.2 Canada Cell-Free DNA (cfDNA) Testing Market
9.1.5.2.1 Canada Cell-Free DNA (cfDNA) Testing Market by Type
9.1.5.2.2 Canada Cell-Free DNA (cfDNA) Testing Market by Application
9.1.5.3 Mexico Cell-Free DNA (cfDNA) Testing Market
9.1.5.3.1 Mexico Cell-Free DNA (cfDNA) Testing Market by Type
9.1.5.3.2 Mexico Cell-Free DNA (cfDNA) Testing Market by Application
9.2. EUROPE
9.2.1 Europe Cell-Free DNA (cfDNA) Testing Market Overview
9.2.2 Europe Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis
9.2.3 Europe Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Type
9.2.4 Europe Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Application
9.2.5 Europe Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Cell-Free DNA (cfDNA) Testing Market
9.2.5.1.1 Germany Cell-Free DNA (cfDNA) Testing Market by Type
9.2.5.1.2 Germany Cell-Free DNA (cfDNA) Testing Market by Application
9.2.5.2 France Cell-Free DNA (cfDNA) Testing Market
9.2.5.2.1 France Cell-Free DNA (cfDNA) Testing Market by Type
9.2.5.2.2 France Cell-Free DNA (cfDNA) Testing Market by Application
9.2.5.3 Italy Cell-Free DNA (cfDNA) Testing Market
9.2.5.3.1 Italy Cell-Free DNA (cfDNA) Testing Market by Type
9.2.5.3.2 Italy Cell-Free DNA (cfDNA) Testing Market by Application
9.2.5.4 Spain Cell-Free DNA (cfDNA) Testing Market
9.2.5.4.1 Spain Cell-Free DNA (cfDNA) Testing Market by Type
9.2.5.4.2 Spain Cell-Free DNA (cfDNA) Testing Market by Application
9.2.5.5 United Kingdom Cell-Free DNA (cfDNA) Testing Market
9.2.5.5.1 United Kingdom Cell-Free DNA (cfDNA) Testing Market by Type
9.2.5.5.2 United Kingdom Cell-Free DNA (cfDNA) Testing Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Overview
9.3.2 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis
9.3.3 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Cell-Free DNA (cfDNA) Testing Market
9.3.5.1.1 Australia Cell-Free DNA (cfDNA) Testing Market by Type
9.3.5.1.2 Australia Cell-Free DNA (cfDNA) Testing Market by Application
9.3.5.2 China Cell-Free DNA (cfDNA) Testing Market
9.3.5.2.1 China Cell-Free DNA (cfDNA) Testing Market by Type
9.3.5.2.2 China Cell-Free DNA (cfDNA) Testing Market by Application
9.3.5.3 India Cell-Free DNA (cfDNA) Testing Market
9.3.5.3.1 India Cell-Free DNA (cfDNA) Testing Market by Type
9.3.5.3.2 India Cell-Free DNA (cfDNA) Testing Market by Application
9.3.5.4 Japan Cell-Free DNA (cfDNA) Testing Market
9.3.5.4.1 Japan Cell-Free DNA (cfDNA) Testing Market by Type
9.3.5.4.2 Japan Cell-Free DNA (cfDNA) Testing Market by Application
9.3.5.5 South Korea Cell-Free DNA (cfDNA) Testing Market
9.3.5.5.1 South Korea Cell-Free DNA (cfDNA) Testing Market by Type
9.3.5.5.2 South Korea Cell-Free DNA (cfDNA) Testing Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Overview
9.4.2 Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis
9.4.3 Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Cell-Free DNA (cfDNA) Testing Market
9.4.5.1.1 South Africa Cell-Free DNA (cfDNA) Testing Market by Type
9.4.5.1.2 South Africa Cell-Free DNA (cfDNA) Testing Market by Application
9.4.5.2 Saudi Arabia Cell-Free DNA (cfDNA) Testing Market
9.4.5.2.1 Saudi Arabia Cell-Free DNA (cfDNA) Testing Market by Type
9.4.5.2.2 Saudi Arabia Cell-Free DNA (cfDNA) Testing Market by Application
9.4.5.3 U.A.E Cell-Free DNA (cfDNA) Testing Market
9.4.5.3.1 U.A.E Cell-Free DNA (cfDNA) Testing Market by Type
9.4.5.3.2 U.A.E Cell-Free DNA (cfDNA) Testing Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Cell-Free DNA (cfDNA) Testing Market Overview
9.5.2 South and Central America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis
9.5.3 South and Central America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Type
9.5.4 South and Central America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Application
9.5.5 South and Central America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Cell-Free DNA (cfDNA) Testing Market
9.5.5.1.1 Brazil Cell-Free DNA (cfDNA) Testing Market by Type
9.5.5.1.2 Brazil Cell-Free DNA (cfDNA) Testing Market by Application
9.5.5.2 Argentina Cell-Free DNA (cfDNA) Testing Market
9.5.5.2.1 Argentina Cell-Free DNA (cfDNA) Testing Market by Type
9.5.5.2.2 Argentina Cell-Free DNA (cfDNA) Testing Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CELL-FREE DNA (CFDNA) TESTING MARKET, KEY COMPANY PROFILES
12.1. AGILENT TECHNOLOGY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ALLENEX AB
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BIOCEPT, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIODESIX, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CAREDX, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GUARDANT HEALTH, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ILLUMANIA, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. INIVATED LIMITED, NATERA, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. QUEST DIAGNOSTICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ROCHE HOLDINGS AG
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
12.11. SEQUENOM, INC.
12.11.1. Key Facts
12.11.2. Business Description
12.11.3. Products and Services
12.11.4. Financial Overview
12.11.5. SWOT Analysis
12.11.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cell-Free DNA (cfDNA) Testing Market - By Type
1.3.2 Cell-Free DNA (cfDNA) Testing Market - By Application
1.3.3 Cell-Free DNA (cfDNA) Testing Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CELL-FREE DNA (CFDNA) TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CELL-FREE DNA (CFDNA) TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CELL-FREE DNA (CFDNA) TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. CELL-FREE DNA (CFDNA) TESTING - GLOBAL MARKET OVERVIEW
6.2. CELL-FREE DNA (CFDNA) TESTING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. CELL-FREE DNA (CFDNA) TESTING MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. DONOR DERIVED CELL FREE DNA (DDCFDNA)
7.3.1. Overview
7.3.2. donor derived cell free DNA (ddcfDNA) Market Forecast and Analysis
7.4. CIRCULATING CELL-FREE TUMOR DNA (CTDNA)
7.4.1. Overview
7.4.2. circulating cell-free tumor DNA (ctDNA) Market Forecast and Analysis
7.5. CELL-FREE FETAL DNA (NIPT)
7.5.1. Overview
7.5.2. cell-free fetal DNA (NIPT) Market Forecast and Analysis
8. CELL-FREE DNA (CFDNA) TESTING MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ONCOLOGY
8.3.1. Overview
8.3.2. oncology Market Forecast and Analysis
8.4. GYNECOLOGY
8.4.1. Overview
8.4.2. gynecology Market Forecast and Analysis
8.5. TRANSPLANTATION
8.5.1. Overview
8.5.2. transplantation Market Forecast and Analysis
9. CELL-FREE DNA (CFDNA) TESTING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Cell-Free DNA (cfDNA) Testing Market Overview
9.1.2 North America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis
9.1.3 North America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Type
9.1.4 North America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Application
9.1.5 North America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Countries
9.1.5.1 United States Cell-Free DNA (cfDNA) Testing Market
9.1.5.1.1 United States Cell-Free DNA (cfDNA) Testing Market by Type
9.1.5.1.2 United States Cell-Free DNA (cfDNA) Testing Market by Application
9.1.5.2 Canada Cell-Free DNA (cfDNA) Testing Market
9.1.5.2.1 Canada Cell-Free DNA (cfDNA) Testing Market by Type
9.1.5.2.2 Canada Cell-Free DNA (cfDNA) Testing Market by Application
9.1.5.3 Mexico Cell-Free DNA (cfDNA) Testing Market
9.1.5.3.1 Mexico Cell-Free DNA (cfDNA) Testing Market by Type
9.1.5.3.2 Mexico Cell-Free DNA (cfDNA) Testing Market by Application
9.2. EUROPE
9.2.1 Europe Cell-Free DNA (cfDNA) Testing Market Overview
9.2.2 Europe Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis
9.2.3 Europe Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Type
9.2.4 Europe Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Application
9.2.5 Europe Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Cell-Free DNA (cfDNA) Testing Market
9.2.5.1.1 Germany Cell-Free DNA (cfDNA) Testing Market by Type
9.2.5.1.2 Germany Cell-Free DNA (cfDNA) Testing Market by Application
9.2.5.2 France Cell-Free DNA (cfDNA) Testing Market
9.2.5.2.1 France Cell-Free DNA (cfDNA) Testing Market by Type
9.2.5.2.2 France Cell-Free DNA (cfDNA) Testing Market by Application
9.2.5.3 Italy Cell-Free DNA (cfDNA) Testing Market
9.2.5.3.1 Italy Cell-Free DNA (cfDNA) Testing Market by Type
9.2.5.3.2 Italy Cell-Free DNA (cfDNA) Testing Market by Application
9.2.5.4 Spain Cell-Free DNA (cfDNA) Testing Market
9.2.5.4.1 Spain Cell-Free DNA (cfDNA) Testing Market by Type
9.2.5.4.2 Spain Cell-Free DNA (cfDNA) Testing Market by Application
9.2.5.5 United Kingdom Cell-Free DNA (cfDNA) Testing Market
9.2.5.5.1 United Kingdom Cell-Free DNA (cfDNA) Testing Market by Type
9.2.5.5.2 United Kingdom Cell-Free DNA (cfDNA) Testing Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Overview
9.3.2 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis
9.3.3 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Cell-Free DNA (cfDNA) Testing Market
9.3.5.1.1 Australia Cell-Free DNA (cfDNA) Testing Market by Type
9.3.5.1.2 Australia Cell-Free DNA (cfDNA) Testing Market by Application
9.3.5.2 China Cell-Free DNA (cfDNA) Testing Market
9.3.5.2.1 China Cell-Free DNA (cfDNA) Testing Market by Type
9.3.5.2.2 China Cell-Free DNA (cfDNA) Testing Market by Application
9.3.5.3 India Cell-Free DNA (cfDNA) Testing Market
9.3.5.3.1 India Cell-Free DNA (cfDNA) Testing Market by Type
9.3.5.3.2 India Cell-Free DNA (cfDNA) Testing Market by Application
9.3.5.4 Japan Cell-Free DNA (cfDNA) Testing Market
9.3.5.4.1 Japan Cell-Free DNA (cfDNA) Testing Market by Type
9.3.5.4.2 Japan Cell-Free DNA (cfDNA) Testing Market by Application
9.3.5.5 South Korea Cell-Free DNA (cfDNA) Testing Market
9.3.5.5.1 South Korea Cell-Free DNA (cfDNA) Testing Market by Type
9.3.5.5.2 South Korea Cell-Free DNA (cfDNA) Testing Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Overview
9.4.2 Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis
9.4.3 Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Cell-Free DNA (cfDNA) Testing Market
9.4.5.1.1 South Africa Cell-Free DNA (cfDNA) Testing Market by Type
9.4.5.1.2 South Africa Cell-Free DNA (cfDNA) Testing Market by Application
9.4.5.2 Saudi Arabia Cell-Free DNA (cfDNA) Testing Market
9.4.5.2.1 Saudi Arabia Cell-Free DNA (cfDNA) Testing Market by Type
9.4.5.2.2 Saudi Arabia Cell-Free DNA (cfDNA) Testing Market by Application
9.4.5.3 U.A.E Cell-Free DNA (cfDNA) Testing Market
9.4.5.3.1 U.A.E Cell-Free DNA (cfDNA) Testing Market by Type
9.4.5.3.2 U.A.E Cell-Free DNA (cfDNA) Testing Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Cell-Free DNA (cfDNA) Testing Market Overview
9.5.2 South and Central America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis
9.5.3 South and Central America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Type
9.5.4 South and Central America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Application
9.5.5 South and Central America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Cell-Free DNA (cfDNA) Testing Market
9.5.5.1.1 Brazil Cell-Free DNA (cfDNA) Testing Market by Type
9.5.5.1.2 Brazil Cell-Free DNA (cfDNA) Testing Market by Application
9.5.5.2 Argentina Cell-Free DNA (cfDNA) Testing Market
9.5.5.2.1 Argentina Cell-Free DNA (cfDNA) Testing Market by Type
9.5.5.2.2 Argentina Cell-Free DNA (cfDNA) Testing Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CELL-FREE DNA (CFDNA) TESTING MARKET, KEY COMPANY PROFILES
12.1. AGILENT TECHNOLOGY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ALLENEX AB
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BIOCEPT, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIODESIX, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CAREDX, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GUARDANT HEALTH, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ILLUMANIA, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. INIVATED LIMITED, NATERA, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. QUEST DIAGNOSTICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ROCHE HOLDINGS AG
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
12.11. SEQUENOM, INC.
12.11.1. Key Facts
12.11.2. Business Description
12.11.3. Products and Services
12.11.4. Financial Overview
12.11.5. SWOT Analysis
12.11.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Agilent Technology
2. Allenex AB
3. Biocept, Inc.
4. Biodesix, Inc.
5. CareDx, Inc.
6. Guardant Health, Inc.
7. Illumania, Inc.
8. Inivated Limited, Natera, Inc.
9. Quest Diagnostics
10. Roche Holdings AG
11. Sequenom, Inc.
1. Agilent Technology
2. Allenex AB
3. Biocept, Inc.
4. Biodesix, Inc.
5. CareDx, Inc.
6. Guardant Health, Inc.
7. Illumania, Inc.
8. Inivated Limited, Natera, Inc.
9. Quest Diagnostics
10. Roche Holdings AG
11. Sequenom, Inc.
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount